The main purpose of this legislation is to ensure that whole genome and whole exome sequencing is covered under the Medicaid program for children who have specific medical needs. This type of genetic testing can help diagnose genetic disorders, rare diseases, and other health conditions that may not have a clear origin. Key provisions of the legislation include a clear definition of whole genome and whole exome sequencing, which involves analyzing a person's DNA to identify potential genetic issues.